Piracetam
CAS number: 7491-74-9
Molecular formula: C6H10N2O2
molecular weight: 142.16
Chemical structure:
Producers shown on SFDA
(Record date:05/09/2021)
Producer | Documents | GMP Valid till(based on SFDA) |
Jiangxi Yuehua Pharmaceutical Co., Ltd. | GMP, DMF | Valid till July 2023 |
Northeast Pharmaceutical Group Co., Ltd. | GMP, DMF | Valid till April 2020 |
Tianjin Zhongjin Pharmaceutical Co., Ltd. | GMP | Valid till February 2018 |
Shanghai Xiandai Hasen(Shangqiu) Pharmaceutical Co., Ltd. | GMP, DMF | Valid till March 2024 |
Huazhong Pharmaceutical Co., Ltd. | GMP | Valid till February 2021 |
Producers shown on EP
(Quoted from EP website;record date:05/09/2021)
Substance | Certificate Holder | Certificate Number | Issue Date | Status | End date | Type |
Piracetam | EGIS Pharmaceuticals PLC HU 1106 Budapest | R1-CEP 2005-136-Rev 01 | 19/04/2021 | VALID | / | Chemistry |
Piracetam | NORTHEAST PHARMACEUTICAL GROUP COMPANY, LIMITED CN 110 027 Shenyang | R1-CEP 2004-083-Rev 07 | 21/04/2021 | VALID | / | Chemistry |
Piracetam | Farchemia S.r.l. IT 24047 Treviglio | R0-CEP 2004-151-Rev 00 | 30/06/2006 | WITHDRAWN BY HOLDER | 22/12/2010 | Chemistry |
Piracetam | PHARMACEUTICAL WORKS POLPHARMA S.A. PL 83-200 Starogard Gdanski | R1-CEP 2004-069-Rev 04 | 06/05/2021 | VALID | / | Chemistry |
Piracetam | MICROSIN S.R.L. RO 032364 Bucharest | R1-CEP 2009-210-Rev 01 | 11/08/2021 | VALID | / | Chemistry |
Producer:Jiangxi Yuehua Pharmaceutical Co., Ltd., founded in 1968, is now a wholly-owned state-owned unit, subordinate to Jingdezhen black cat Group Co., Ltd., a first-class legal person enterprise. The current plant site is located in the chemical centralized control zone of Jingdezhen high tech Industrial Development Zone, Jiangxi Province. The main products are piracetam (Naofukang), sodium methoxide and methanol solution, with an average annual production capacity of 2000 tons. The plant covers an area of 310 mu (110 mu for the old plant and 200 mu for the new plant), and now has 220 employees, including 68 professional and technical personnel, 14 with intermediate titles and 3 with senior titles.
Staff size:200-299 persons
Registered capital:RMB 12.53 million
Producer:Northeast Pharmaceutical Group Co., Ltd. is a listed company of Liaoning Fangda Group Industry Co., Ltd. The company, formerly known as Northeast Pharmaceutical General Factory, was founded in 1946.
The preparation production base covers an area of 180000 square meters, with more than 30 production lines and an annual production capacity of 10 billion tablets (sticks, pills, granules, pieces and bottles). The API production base covers an area of 910000 square meters. It is a national intelligent manufacturing demonstration factory for bulk APIs and pharmaceutical intermediates.
The product quality complies with the latest quality standards such as GMP, EP, USP, JP, BP and CP. Many products have passed international high-end certification such as EDQM, FDA, Japan's Ministry of health and welfare, BRC, halal, kosher, etc. The leading products have passed the registration and quality audit in the United States, Europe, Japan, Brazil, Russia, Poland and other countries and regions.
Staff size:About 8000 persons
Registered capital:RMB 1 billion 348 million
Producer:Tianjin Zhongjin Pharmaceutical Co., Ltd., with total assets of more than 120 million yuan, covers an area of 120000 square meters and a construction area of 30000 square meters. The company has plants, workshop equipment, testing instruments and processes. The service field is the production of API (vitamin B1, thiamine nitrate, piracetam and pidotimod)
。 Among them, vitamin B1 is rated as a famous brand product in Tianjin, which meets the standards of multinational Pharmacopoeia (chp2000, USP25, BP2000, jp13, etc.), with an annual output of 1200 tons. 95% of the products are exported and sold in dozens of countries and regions.
Staff size:About 50 persons
Registered capital:RMB 126.25 million
Producer:Shanghai Xiandai Hasen(Shangqiu) Pharmaceutical Co., Ltd.is a holding company invested and established by the listed company Shanghai Hyundai Pharmaceutical Co., Ltd. (stock code 600420). The major shareholder is China Pharmaceutical Group Corporation. It is a pharmaceutical enterprise built in strict accordance with the modern enterprise system and the requirements of national GMP. It is a diversified enterprise integrating drug R & D, production and sales Modern national essential drug production base. The company covers an area of more than 500 mu, has a registered capital of 83.29 million yuan, a total asset of more than 600 million yuan, and has more than 1600 employees, including more than 800 professional and technical personnel; The company has obtained 163 drug production approval products, and has GMP production lines for small volume injections, oral solid preparations (tablets, capsules, granules), APIs and other dosage forms. The annual production capacity of small volume injections is 4 billion tubes, 6 billion tablets (granules and bags) of oral solid preparations and 1200 tons of API.
Staff size:1000-1999 persons
Registered capital:RMB 83.29 million
Producer:Huazhong Pharmaceutical Co., Ltd. is subordinate to China Ordnance Equipment Group Corporation. It is located in Xiangyang City, an important town in Northwest Hubei Province with beautiful scenery and rich resources. It covers an area of 700000 square meters. It is a modern comprehensive pharmaceutical enterprise integrating R & D, production and sales of pharmaceutical products. The company has strong technical force, complete quality testing equipment and quality assurance system, advanced production technology and equipment, and has passed GMP, fami-qs, HACCP, ISO9001, ISO22000, kosher, halal and other certifications.
Subsidiaries of Huazhong Pharmaceutical Co., Ltd.: Hubei 295 Technology Co., Ltd. and Xiangfan 295 Pharmaceutical Trading Co., Ltd. We are the earliest manufacturer of vitamin B1 raw materials in China and the largest in the world. The product quality meets the quality standards of CP, BP, USP, EP and JP. At the same time, we have also developed VB1 Granule Series and VB1 derivative series products.
Staff size:600-699 persons
Registered capital:RMB 245 million 148 thousand and 515
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978